Association between mood characteristics and polymorphisms of glial cell line-derived neurotrophic factor (GNDF) in patients with depression;A hangulati dimenziók és a glia-eredet{double acute} növekedési faktort kódoló gén polimorfizmusainak összefüggése depresszióval diagnosztizált mintán

Neuropsychopharmacologia Hungarica

Volumn 15, Issue 2, 2013, Pages 63-72

  Eszter, Kotyuk ^a   Nóra, Németh ^b   Zsuzsa, Halmai ^b   Gábor, Faludi ^b   Mária, Sasvári Székely ^b   Anna, És Székely ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Bipolar depression; Glial cell line derived neurotrophic factor (GNDF); Hospital anxiety and depression scale; Major depression; Rs3096140; Rs3812047

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

ALLELE; ANXIETY; ARTICLE; BIPOLAR DEPRESSION; CASE CONTROL STUDY; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MOOD CHANGE;

ADULT; AFFECT; AGED; ANXIETY; BIPOLAR DISORDER; CASE-CONTROL STUDIES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENE FREQUENCY; GENOTYPE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; HUNGARY; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84879293359     PISSN: 14198711     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Argyelan, M., Szabo, Z., Kanyo, B., Tanacs, A., Kovacs, Z., Janka, Z., Pavics, L. (2005) Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord, 89:115-23.
2. Bagdy, G., Juhasz, G., Gonda, X. (2012) A new clinical evidence-based gene-environment interaction model of depression. Neuropsychopharmacol Hung, 14:213-20.
3. Barbosa, I. G., Huguet, R. B., Sousa, L. P., Abreu, M. N., Rocha, N. P., Bauer, M. E., Carvalho, L. A., Teixeira, A. L. (2011) Circulating levels of GDNF in bipolar disorder. Neurosci Lett, 502:103-6.
4. Bjelland, I., Dahl, A. A., Haug, T. T., Neckelmann, D. (2002) The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res, 52:69-77.
5. Breslau, N. (1995) Psychiatric comorbidity of smoking and nicotine dependence. Behav Genet, 25:95-101.
6. Compton, W. M., 3rd, Cottler, L. B., Jacobs, J. L., Ben-Abdallah, A., Spitznagel, E. L. (2003) The role of psychiatric disorders in predicting drug dependence treatment outcomes. Am J Psychiatry, 160:890-5.
7. Conway, K. P., Compton, W., Stinson, F. S., Grant, B. F. (2006) Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry, 67:247-57.
8. Cuellar, A. K., Johnson, S. L., Winters, R. (2005) Distinctions between bipolar and unipolar depression. Clin Psychol Rev, 25:307-39.
9. Diniz, B. S., Teixeira, A. L., Miranda, A. S., Talib, L. L., Gattaz, W. F., Forlenza, O. V. (2012) Circulating Glial-derived neurotrophic factor is reduced in late-life depression. J Psychiatr Res, 46:135-9.
10. Du, L., Faludi, G., Palkovits, M., Sotonyi, P., Bakish, D., Hrdina, P. D. (2002) High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport, 13:1195-8.
11. Faludi, G., Gonda, X., Bagdy, G., Dome, P. (2012) Pharmaco and therapygenetic aspects in the treatment of anxiety disorders beyond the serotonergic system: a brief review. Neuropsy chopharmacol Hung, 14:221-9.
12. Farrell, M., Howes, S., Bebbington, P., Brugha, T., Jenkins, R., Lewis, G., Marsden, J., Taylor, C., Meltzer, H. (2001) Nicotine, alcohol and drug dependence and psychiatric comorbidity. Results of a national household survey. Br J Psychiatry, 179:432-7.
13. Gill, S. S., Patel, N. K., Hotton, G. R., O'Sullivan, K., McCarter, R., Bunnage, M., Brooks, D. J., Svendsen, C. N., Heywood, P. (2003) Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med, 9:589-95.
14. Granholm, A. C., Reyland, M., Albeck, D., Sanders, L., Gerhardt, G., Hoernig, G., Shen, L., Westphal, H., Hoffer, B. (2000) Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. J Neurosci, 20:3182-90.
15. Grant, B. F. (1995) Comorbidity between DSM-IV drug use disorders and major depression: results of a national survey of adults. J Subst Abuse, 7:481-97.
16. Greenwood, T. A., Alexander, M., Keck, P. E., McElroy, S., Sadovnick, A. D., Remick, R. A., Kelsoe, J. R. (2001) Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet, 105:145-51.
17. Helzer, J. E., Pryzbeck, T. R. (1988) The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol, 49:219-24.
18. Herrmann, C. (1997) International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J Psychosom Res, 42:17-41.
19. Hunnerkopf, R., Strobel, A., Gutknecht, L., Brocke, B., Lesch, K. P. (2007) Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology, 32:2552-60.
20. Kelsoe, J. R. (2003) Arguments for the genetic basis of the bipolar spectrum. J Affect Disord, 73:183-97.
21. Kendler, K. S., Neale, M. C., MacLean, C. J., Heath, A. C., Eaves, L. J., Kessler, R. C. (1993) Smoking and major depression. A causal analysis. Arch Gen Psychiatry, 50:36-43.
22. Khantzian, E. J. (1985) The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry, 142:1259-64.
23. Kotyuk, E., Keszler, G., Nemeth, N., Ronai, Z., Sasvari-Szekely, M., Szekely, A. (kézirat beküldve) Glial cell line-derived neurotrophic factor (GDNF) as a novel candidate gene of anxiety. Am J Med Genet B Neuropsychiatr Genet.
24. Kotyuk, E., Kovacs-Nagy, R., Faludi, G., Urban, R., Ronai, Z., Sasvari-Szekely, M., Szekely, A. (2009) [Association between nicotine dependence and the -521 promoter polymorfism of the dopamine D4 receptor in patients with major depression]. Neuropsychopharmacol Hung, 11:59-67.
25. Kozicz, T., Tilburg-Ouwens, D., Faludi, G., Palkovits, M., Roubos, E. (2008) Gender-related urocortin 1 and brain-derived neurotrophic factor expression in the adult human midbrain of suicide victims with major depression. Neuroscience, 152:1015-23.
26. Krishnan, V., Nestler, E. J. (2008) The molecular neurobiology of depression. Nature, 455:894-902.
27. Laurin, N., Lee, J., Ickowicz, A., Pathare, T., Malone, M., Tannock, R., Kennedy, J. L., Schachar, R. J., Barr, C. L. (2008) Association study for genes at chromosome 5p13-q11 in attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet, 147B:600-5.
28. Lee, K., Kunugi, H., Nanko, S. (2001) Glial cell line-derived neurotrophic factor (GDNF) gene and schizophrenia: polymorphism screening and association analysis. Psychiatry Res, 104:11-7.
29. Lopez Leon, S., Croes, E. A., Sayed-Tabatabaei, F. A., Claes, S., Van Broeckhoven, C., van Duijn, C. M. (2005) The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis. Biol Psychiatry, 57:999-1003.
30. Loria, M. J., White, S. W., Robbins, S. A., Salmeto, A. L., Hymel, K. A., Murthy, S. N., Manda, P., Sufka, K. J. (2013) Brain-derived neurotrophic factor response in vulnerable and resilient genetic lines in the chick anxiety-depression model. Behav Brain Res, in press.
31. Markou, A., Kosten, T. R., Koob, G. F. (1998) Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology, 18:135-74.
32. Michel, T. M., Frangou, S., Camara, S., Thiemeyer, D., Jecel, J., Tatschner, T., Zoechling, R., Grunblatt, E. (2008) Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder: a comparative post-mortem study. Eur Psychiatry, 23:413-20.
33. Michelato, A., Bonvicini, C., Ventriglia, M., Scassellati, C., Randazzo, R., Bignotti, S., Beneduce, R., Riva, M. A., Gennarelli, M. (2004) 3' UTR (AGG)n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neurosci Lett, 357:235-7.
34. Mueller, T. I., Lavori, P. W., Keller, M. B., Swartz, A., Warshaw, M., Hasin, D., Coryell, W., Endicott, J., Rice, J., Akiskal, H. (1994) Prognostic effect of the variable course of alcoholism on the 10-year course of depression. Am J Psychiatry, 151:701-6.
35. Muszbek, K., Szekely, A., Balogh, E. M., Molnar, M., Rohanszky, M., Ruzsa, A., Varga, K., Szollosi, M., Vadasz, P. (2006) Validation of the Hungarian translation of Hospital Anxiety and Depression Scale. Qual Life Res, 15:761-6.
36. Nitta, A., Nishioka, H., Fukumitsu, H., Furukawa, Y., Sugiura, H., Shen, L., Furukawa, S. (2004) Hydrophobic dipeptide LeuIle protects against neuronal death by inducing brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis. J Neurosci Res, 78:250-8.
37. Nutt, J. G., Burchiel, K. J., Comella, C. L., Jankovic, J., Lang, A. E., Laws, E. R., Jr., Lozano, A. M., Penn, R. D., Simpson, R. K., Jr., Stacy, M., Wooten, G. F., factor, I. G. S. G. I. i. G. c. l.-d. n. (2003) Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology, 60:69-73.
38. Otsuki, K., Uchida, S., Watanuki, T., Wakabayashi, Y., Fujimoto, M., Matsubara, T., Funato, H., Watanabe, Y. (2008) Altered expression of neurotrophic factors in patients with major depression. J Psychiatr Res, 42:1145-53.
39. Patel, N. K., Gill, S. S. (2007) GDNF delivery for Parkinson's disease. Acta Neurochir Suppl, 97:135-54.
40. Rosa, A. R., Frey, B. N., Andreazza, A. C., Cereser, K. M., Cunha, A. B., Quevedo, J., Santin, A., Gottfried, C., Goncalves, C. A., Vieta, E., Kapczinski, F. (2006) Increased serum glial cell line derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett, 407:146-50.
41. Ruhe, H. G., Mason, N. S., Schene, A. H. (2007) Mood is in directly related to serotonin, norepinephrine and dopamine levels in humans: a meta-analysis of monoamine depletion studies. Mol Psychiatry, 12:331-59.
42. Serretti, A., Lilli, R., Lorenzi, C., Lattuada, E., Smeraldi, E. (2001) DRD4 exon 3 variants associated with delusional symptomatology in major psychoses: a study on 2,011 affected subjects. Am J Med Genet, 105:283-90.
43. Sklar, P., Gabriel, S. B., McInnis, M. G., Bennett, P., Lim, Y., Tsan, G., Schaffner, S., Kirov, G., Jones, I., Owen, M., Craddock, N., DePaulo, J. R., Lander, E. S. (2002) Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiatry, 7:579-93.
44. Stevenson, J. R., Schroeder, J. P., Nixon, K., Besheer, J., Crews, F. T., Hodge, C. W. (2009) Abstinence following alcohol drinking produces depression-like behavior and reduced hippocampal neurogenesis in mice. Neuropsychopharmacology, 34:1209-22.
45. Strauss, J., Barr, C. L., George, C. J., Devlin, B., Vetro, A., Kiss, E., Baji, I., King, N., Shaikh, S., Lanktree, M., Kovacs, M., Kennedy, J. L. (2005) Brain-derived neurotrophic factor variants are associated with childhood-onset mood disorder: confirmation in a Hungarian sample. Mol Psychiatry, 10:861-7.
46. Syed, Z., Dudbridge, F., Kent, L. (2007) An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD. Am J Med Genet B Neuropsychiatr Genet, 144B:375-8.
47. Torzsa, P., Rihmer, Z., Gonda, X., Sebestyén, B., Szokontor, N., Kalabay, L. (2008) [Prevalence of major depression in primary care practices in Hungary]. Neuropsychopharmacol Hung, 10:265-70.
48. Wang, X., Hou, Z., Yuan, Y., Hou, G., Liu, Y., Li, H., Zhang, Z. (2011) Association study between plasma GDNF and cognitive function in late-onset depression. J Affect Disord, 132:418-21.
49. Williams, H. J., Norton, N., Peirce, T., Dwyer, S., Williams, N. M., Moskvina, V., Owen, M. J., O'Donovan, M. C. (2007) Association analysis of the glial cell line-derived neurotrophic factor (GDNF) gene in schizophrenia. Schizophr Res, 97:271-6.
50. Yasuhara, T., Shingo, T., Date, I. (2007) Glial cell line-derived neurotrophic factor (GDNF) therapy for Parkinson's disease. Acta Med Okayama, 61:51-6.
51. Yoshimura, T., Usui, H., Takahashi, N., Yoshimi, A., Saito, S., Aleksic, B., Ujike, H., Inada, T., Yamada, M., Uchimura, N., Iwata, N., Sora, I., Iyo, M., Ozaki, N. (2011) Association analysis of the GDNF gene with methamphetamine use disorder in a Japanese population. Prog Neuropsychopharmacol Biol Psychiatry, 35:1268-72.
52. Zigmond, A. S., Snaith, R. P. (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand, 67:361-70.